X4 Pharmaceuticals Inc
NASDAQ:XFOR

Watchlist Manager
X4 Pharmaceuticals Inc Logo
X4 Pharmaceuticals Inc
NASDAQ:XFOR
Watchlist
Price: 3.91 USD 0.77% Market Closed
Market Cap: 341.9m USD

Wall Street
Price Targets

XFOR Price Targets Summary
X4 Pharmaceuticals Inc

Wall Street analysts forecast XFOR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for XFOR is 8.16 USD with a low forecast of 4.04 USD and a high forecast of 13.65 USD.

Lowest
Price Target
4.04 USD
3% Upside
Average
Price Target
8.16 USD
109% Upside
Highest
Price Target
13.65 USD
249% Upside
X4 Pharmaceuticals Inc Competitors:
Price Targets
ENTA
Enanta Pharmaceuticals Inc
32% Upside
BMRN
Biomarin Pharmaceutical Inc
74% Upside
ARGX
argenx SE
12% Upside
OPK
OPKO Health Inc
171% Upside
2171
CARsgen Therapeutics Holdings Ltd
48% Upside
196170
Alteogen Inc
25% Upside
300896
Imeik Technology Development Co Ltd
43% Upside
ARQT
Arcutis Biotherapeutics Inc
11% Upside

Revenue
Forecast

Revenue Estimate
X4 Pharmaceuticals Inc

The compound annual growth rate of X4 Pharmaceuticals Inc's revenue for the next 4 years is 160%.

N/A
Past Growth
160%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
X4 Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
X4 Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-99%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is XFOR's stock price target?
Price Target
8.16 USD

According to Wall Street analysts, the average 1-year price target for XFOR is 8.16 USD with a low forecast of 4.04 USD and a high forecast of 13.65 USD.

What is X4 Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
160%

The compound annual growth rate of X4 Pharmaceuticals Inc's revenue for the next 4 years is 160%.

Back to Top